Jens Juul Holst

Jens Juul Holst

Professor


  1. 2002
  2. Published

    Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1?

    Holst, Jens Juul, 2002, In: BioDrugs. 16, 3, p. 175-81 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Gliclazide directly inhibits arginine-induced glucagon release.

    Cejvan, K., Coy, D. H., Holst, Jens Juul, Cerasi, E. & Efendic, S., 2002, In: Diabetes. 51 Suppl 3, p. S381-4

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats.

    Hartmann, B., Thulesen, J., Hare, K. J., Kissow, Hannelouise, Orskov, C., Poulsen, Steen Seier & Holst, Jens Juul, 2002, In: Regulatory Peptides. 105, 3, p. 173-9 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Inhibition of gastric inhibitory polypeptide signaling prevents obesity.

    Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., Hiai, H., Mizunoya, W., Fushiki, T., Holst, J. J., Makino, M., Tashita, A., Kobara, Y., Tsubamoto, Y., Jinnouchi, T., Jomori, T. & 1 others, Seino, Y., 2002, In: Nature Medicine. 8, 7, p. 738-42 4 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice

    Reimer, M. K., Holst, Jens Juul & Ahrén, B., 2002, In: European Journal of Endocrinology. 146, p. 717-727

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Postprandial glucose, insulin and incretin responses to grain products in healthy subjects

    Juntunen, K. S., Lioukkonen, H. K., Poutanen, S. K., Niskanen, K. L., Holst, Jens Juul & Mykkänen, M. H., 2002, In: Am. J. Clin. Nutr.. 75, p. 254-262

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Preservation of active Effects of topical ropivacaine om eicosanoids and neurotransmitters in the rectum of patients with distal ulcerative colitis

    Hillingsøe, J. G., Kjeldsen, J., Schmidt, P. T., Rasmussen, T. N., Arlander, E., Fischer-Hansen, B., Holst, Jens Juul, Lauritsen, K., Bukhave, K. & Rask-Madsen, J., 2002, In: Scandinavian Journal of Gastroenterology. 37, p. 325-329

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Short-term administration of Glucagon-like peptide-2. Effects on bone mass density and markers of bone remodelling in short bowel patients with no colon

    Haderslev, K. V., Jeppesen, P. B., Hartmann, B., Thulesen, J., Sørensen, H. A., Graff, J., Hansen, B. S., Tofteng, F., Poulsen, Steen Seier, Madsen, J. L., Holst, Jens Juul, Staun, M. & Mortensen, P. B., 2002, In: Scandinavian Journal of Gastroenterology. vol. 37, p. 392-398

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist.

    Thulesen, J., Knudsen, L. B., Hartmann, B., Hastrup, S., Kissow, Hannelouise, Jeppesen, P. B., Ørskov, Cathrine, Holst, Jens Juul & Poulsen, Steen Seier, 2002, In: Regulatory Peptides. 103, 1, p. 9-15 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1.

    Holst, Jens Juul, 2002, In: Diabetes - Metabolism: Research and Reviews (Print Edition). 18, 6, p. 430-41 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207